207 related articles for article (PubMed ID: 30659022)
1. MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma
Guo Q; Li VZ; Nichol JN; Huang F; Yang W; Preston SEJ; Talat Z; Lefrère H; Yu H; Zhang G; Basik M; Gonçalves C; Zhan Y; Plourde D; Su J; Torres J; Marques M; Habyan SA; Bijian K; Amant F; Witcher M; Behbod F; McCaffrey L; Alaoui-Jamali M; Giannakopoulos NV; Brackstone M; Postovit LM; Del Rincón SV; Miller WH
Cancer Res; 2019 Apr; 79(7):1646-1657. PubMed ID: 30659022
[TBL] [Abstract][Full Text] [Related]
2. Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.
Brock EJ; Jackson RM; Boerner JL; Li Q; Tennis MA; Sloane BF; Mattingly RR
PLoS One; 2021; 16(5):e0252314. PubMed ID: 34048471
[TBL] [Abstract][Full Text] [Related]
3. Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression.
Fang WB; Sofia Acevedo D; Smart C; Zinda B; Alissa N; Warren K; Fraga G; Huang LC; Shyr Y; Li W; Xie L; Staggs V; Hong Y; Behbod F; Cheng N
Sci Rep; 2021 Apr; 11(1):8708. PubMed ID: 33888841
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.
Bertozzi S; Cedolini C; Londero AP; Baita B; Giacomuzzi F; Capobianco D; Tortelli M; Uzzau A; Mariuzzi L; Risaliti A
Medicine (Baltimore); 2019 Jan; 98(1):e13831. PubMed ID: 30608397
[TBL] [Abstract][Full Text] [Related]
6. Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases.
Acevedo DS; Fang WB; Rao V; Penmetcha V; Leyva H; Acosta G; Cote P; Brodine R; Swerdlow R; Tan L; Lorenzi PL; Cheng N
Neoplasia; 2022 Jun; 28():100791. PubMed ID: 35405500
[TBL] [Abstract][Full Text] [Related]
7. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
[TBL] [Abstract][Full Text] [Related]
8. Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer.
Wang S; Li W; Liu N; Zhang F; Liu H; Liu F; Liu J; Zhang T; Niu Y
J Cell Biochem; 2012 Jun; 113(6):1904-14. PubMed ID: 22234886
[TBL] [Abstract][Full Text] [Related]
9. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
[TBL] [Abstract][Full Text] [Related]
11. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
12. Everolimus Inhibits the Progression of Ductal Carcinoma
Chen G; Ding XF; Pressley K; Bouamar H; Wang B; Zheng G; Broome LE; Nazarullah A; Brenner AJ; Kaklamani V; Jatoi I; Sun LZ
Clin Cancer Res; 2020 Mar; 26(6):1486-1496. PubMed ID: 31871301
[TBL] [Abstract][Full Text] [Related]
13. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
14. miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
Lee J; Kim HE; Song YS; Cho EY; Lee A
Breast Cancer Res Treat; 2019 Jul; 176(1):119-130. PubMed ID: 30989460
[TBL] [Abstract][Full Text] [Related]
15. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
16. MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.
Yang W; Khoury E; Guo Q; Prabhu SA; Emond A; Huang F; Gonçalves C; Zhan Y; Plourde D; Nichol JN; Dahabieh MS; Miller WH; Del Rincón SV
Oncogene; 2020 Apr; 39(18):3650-3665. PubMed ID: 32132651
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis.
Zubeldia-Plazaola A; Recalde-Percaz L; Moragas N; Alcaraz M; Chen X; Mancino M; Fernández-Nogueira P; Prats de Puig M; Guzman F; Noguera-Castells A; López-Plana A; Enreig E; Carbó N; Almendro V; Gascón P; Bragado P; Fuster G
Breast Cancer Res; 2018 Jul; 20(1):65. PubMed ID: 29973218
[TBL] [Abstract][Full Text] [Related]
18. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
19. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
20. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]